Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of macrophage differentiation. [GOC:go_curators]
Negative regulation of macrophage differentiation is a complex process that involves a variety of signaling pathways and transcription factors. It is essential for maintaining tissue homeostasis and preventing excessive inflammation. Here's a breakdown of the key steps involved:
**1. Inhibition of Macrophage Colony-Stimulating Factor (M-CSF) Signaling:**
- M-CSF is a critical cytokine that promotes the differentiation of monocytes into macrophages.
- Negative regulation can occur by:
- Blocking M-CSF production by cells like fibroblasts and endothelial cells.
- Inhibiting M-CSF receptor (CSF1R) expression on monocytes.
- Interfering with M-CSF binding to CSF1R.
- Downregulating downstream signaling pathways activated by CSF1R, such as the RAS-RAF-MEK-ERK pathway.
**2. Suppression of Transcription Factors Involved in Macrophage Differentiation:**
- Several transcription factors, like PU.1, C/EBPα, and IRF8, play key roles in macrophage differentiation.
- Negative regulation can occur by:
- Inhibiting their expression through epigenetic modifications (e.g., DNA methylation) or by microRNAs.
- Blocking their binding to target genes involved in macrophage differentiation.
**3. Induction of Inhibitory Transcription Factors:**
- Some transcription factors, such as GATA-2 and STAT6, can suppress macrophage differentiation.
- Their expression can be upregulated by signaling pathways like IL-4 signaling, which promotes alternative activation of macrophages (M2 macrophages) that typically suppress inflammation.
**4. Activation of Anti-inflammatory Signaling Pathways:**
- Pathways like the IL-10 signaling pathway can inhibit macrophage differentiation and promote an anti-inflammatory state.
- IL-10 can suppress the expression of pro-inflammatory cytokines and induce the production of anti-inflammatory factors.
**5. Inhibition of Cell Cycle Progression:**
- Macrophage differentiation often involves cell cycle progression.
- Negative regulation can involve:
- Inducing cell cycle arrest in monocytes.
- Downregulating expression of proteins involved in cell cycle control, such as cyclins and CDKs.
**6. Induction of Apoptosis:**
- In some cases, negative regulation of macrophage differentiation can involve inducing programmed cell death (apoptosis) in monocytes, preventing their differentiation into macrophages.
**Factors influencing negative regulation:**
- The specific microenvironment and the presence of various signaling molecules can influence the extent of negative regulation of macrophage differentiation.
- For example, tissue-specific factors or immune responses can modulate the balance between macrophage differentiation and suppression.
In summary, negative regulation of macrophage differentiation is a complex process that involves multiple levels of control. It plays a critical role in maintaining tissue homeostasis, preventing excessive inflammation, and ensuring proper immune function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Tyrosine-protein phosphatase non-receptor type 2 | A tyrosine-protein phosphatase non-receptor type 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17706] | Homo sapiens (human) |
Inhibin alpha chain | An inhibin alpha chain that is encoded in the genome of human. [PRO:CNA, UniProtKB:P05111] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
5-iodo-2-(oxaloamino)benzoic acid | organoiodine compound | ||
lithocholic acid | lithocholate : A bile acid anion that is the conjugate base of lithocholic acid. lithocholic acid : A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action. Lithocholic Acid: A bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic. | bile acid; C24-steroid; monohydroxy-5beta-cholanic acid | geroprotector; human metabolite; mouse metabolite |
glycyrrhetinic acid | cyclic terpene ketone; hydroxy monocarboxylic acid; pentacyclic triterpenoid | immunomodulator; plant metabolite | |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
vanadates | vanadate(3-) : A vanadium oxoanion that is a trianion with formula VO4 in which the vanadium is in the +5 oxidation state and is attached to four oxygen atoms. Vanadates: Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects. | trivalent inorganic anion; vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
madecassic acid | monocarboxylic acid; pentacyclic triterpenoid; tetrol | antioxidant; plant metabolite | |
maslinic acid | (2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoria | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite |
geniposide | terpene glycoside | ||
asiatic acid | monocarboxylic acid; pentacyclic triterpenoid; triol | angiogenesis modulating agent; metabolite | |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
cryptotanshinone | cryptotanshinone: from Salvia miltiorrhiza | abietane diterpenoid | anticoronaviral agent |
boswellic acid | boswellic acid: ursane type; RN given refers to (3alpha,4beta)-isomer; active principle of salai guggal; see also record for salai guggal | triterpenoid | |
procurcumenol | procurcumenol: RN given for (1S-(1alpha,3abeta,8aalpha))-isomer; epiprocurcumenol is the (1S-(1alpha,3aalpha,8aalpha))-isomer; a TNF-alpha antagonist isolated from Curcuma zedoaria; structure in first source | sesquiterpenoid | |
pinocembrin | |||
genipin | iridoid monoterpenoid | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cross-linking reagent; hepatotoxic agent; uncoupling protein inhibitor | |
2-(oxaloamino)benzoic acid | (oxaloamino)benzoic acid | ||
chlorogenic acid | caffeoylquinic acid: Antiviral Agent; structure in first source chlorogenate : A monocarboxylic acid anion that is the conjugate base of chlorogenic acid; major species at pH 7.3. | cinnamate ester; tannin | food component; plant metabolite |
tocopherylquinone | tocopherylquinone: RN refers to (3R-(3R*,7R*,11R*))-isomer; structure | ||
illudalic acid | illudalic acid: isolated from Clitocybe illudens; structure in first source | ||
eupatoriopicrine | germacranolide | ||
cannabigerol | cannabigerol : A member of the class of resorcinols that is resorcinol which is substituted by a (2E)-3,7-dimethylocta-2,6-dien-1-yl group at position 2 and by a pentyl group at position 5. It is a natural product found in Cannabis sativa and Helichrysum species. cannabigerol: RN given refers to (E)-isomer; structure given in first source | phytocannabinoid; resorcinols | anti-inflammatory agent; antibacterial agent; antioxidant; appetite enhancer; cannabinoid receptor agonist; neuroprotective agent; plant metabolite |
2-amino-6-chloropurine | 6-chloroguanine : An organochlorine compound that is 7H-purin-2-amine substituted by a chloro group at position 6. 6-chloroguanine: an antimalarial that inhibits hypoxanthine-guanine-xanthine phosphoribosyltransferase; structure in first source | 2-aminopurines; organochlorine compound | |
corosolic acid | triterpenoid | metabolite | |
11-keto-boswellic acid | |||
3-epioleanolic acid | triterpenoid | metabolite | |
oleanonic acid | oleanonic acid: structure in first source | ||
zedoarondiol | zedoarondiol: structure in first source | ||
formylchromone | formylchromone: structure in first source | ||
rk 682 | |||
variabilin | variabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source |